IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation
Lin, San-Ren1; Ke, Mei-Yun1; Luo, Jin-Yan1; Yuan, Yao-Zong1; Wang, Ji-Yao1; diTommaso, Shelley1; Walter, Verena1; Huang, Jiaqing1
关键词Chronic Constipation Tegaserod China Complete Spontaneous Bowel Movement Placebo-controlled Stool
刊名WORLD JOURNAL OF GASTROENTEROLOGY
2007-02-07
13期:5页:732-739
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Gastroenterology & Hepatology
研究领域[WOS]Gastroenterology & Hepatology
关键词[WOS]IRRITABLE-BOWEL-SYNDROME ; MANAGEMENT ; SYMPTOMS ; TRANSIT
英文摘要

AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d..), in men and women with chronic constipation (CC) from China.

METHODS: This was a multicenter, double-blind, placebo-controlled study. Following a 2-wk treatmentfree baseline period, patients were randomized to receive either tegaserod (6 mg b.i.d.) or placebo (b.i.d.) for 4 wk. An analysis of covariance with repeated measures was used to determine the overall effect of treatment for the primary efficacy variable; the change from baseline in the number of complete spontaneous bowel movements (CSBMs) during the 4-wk treatment period. Secondary efficacy endpoints included other measures of response in terms of CSBMs, and patients′ daily and weekly assessment of bowel habits. Safety was also assessed, based on the incidence and severity of adverse events (AEs).

RESULTS: A total of 607 patients were randomized to receive either tegaserod (n = 304) or placebo (n = 303). Tegaserod treatment resulted in a rapid and significant increase from baseline in the adjusted mean, number of CSBMs per week over wk 1-4 compared with placebo (1.39 vs 0.91, P = 0.0002). A statistically significant difference in favor of tegaserod was also observed for a mean increase >= 1 CSBM/wk over wk 1-4 (47.7% vs 35.0%, tegaserod vs placebo, respectively, P = 0.0018) and for the absolute number of >= 3 CSBMs/wk over wk 1-4 (25.0% vs 14.5%, tegaserod vs placebo, respectively, P = 0.0021). Improvements in other symptoms of CC were also seen in the tegaserod group, including improved stool form and reduced straining. In addition, more patients in the tegaserod group reported satisfactory relief from their constipation symptoms. The frequency and severity of AEs was comparable between tegaserod and placebo groups, with the exception of a greater incidence of diarrhea in patients receiving tegaserod (3.6%) compared with placebo (1.7%).

CONCLUSION: Tegaserod treatment improved multiple symptoms of CC and was associated with a favorable safety profile. (c) 2007 The WJG Press. All rights reserved.

语种英语
WOS记录号WOS:000244087400010
Citation statistics
Cited Times:7[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52097
Collection北京大学第三临床医学院
作者单位1.Shanghai Zhongshan Hosp, Shanghai, Peoples R China
2.Novartis Pharma AG, Basel, Switzerland
3.Shanghai Ruijin Hosp, Shanghai, Peoples R China
4.Beijing Med Univ, Hosp 3, Beijing 100083, Peoples R China
5.Xian Jiaotong Univ, Hosp 2, Shanxi, Peoples R China
6.Novartis Pharmaceut Corp, Gastroenterol Urol Therapeut Area, Clin Dev & Med Affairs, E Hanover, NJ 07936 USA
7.Beijing Union Med Coll Hosp, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Lin, San-Ren,Ke, Mei-Yun,Luo, Jin-Yan,et al. A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation[J]. WORLD JOURNAL OF GASTROENTEROLOGY,2007,13(5):732-739.
APA Lin, San-Ren.,Ke, Mei-Yun.,Luo, Jin-Yan.,Yuan, Yao-Zong.,Wang, Ji-Yao.,...&Huang, Jiaqing.(2007).A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation.WORLD JOURNAL OF GASTROENTEROLOGY,13(5),732-739.
MLA Lin, San-Ren,et al."A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation".WORLD JOURNAL OF GASTROENTEROLOGY 13.5(2007):732-739.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Lin, San-Ren]'s Articles
[Ke, Mei-Yun]'s Articles
[Luo, Jin-Yan]'s Articles
百度学术
百度学术Similar articles in
[Lin, San-Ren]'s Articles
[Ke, Mei-Yun]'s Articles
[Luo, Jin-Yan]'s Articles
必应学术
必应学术Similar articles in
[Lin, San-Ren]'s Articles
[Ke, Mei-Yun]'s Articles
[Luo, Jin-Yan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.